Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (s)-(3-(dimethylamino)azetidin-1-yl)(2-(6-(2-ethyl-4-hydroxyphenyl)-1h-indazol-3-yl)-5-isopropyl-4,5,6,7-tetrahydro-3h-imidazo(4,5-c)pyridin-6-yl)methanone
2. Methanone, (3-(dimethylamino)-1-azetidinyl)((6s)-2-(6-(2-ethyl-4-hydroxyphenyl)-1h-indazol-3-yl)-4,5,6,7-tetrahydro-5-(1-methylethyl)-3h-imidazo(4,5-c)pyridin-6-yl)-, Hydrate (1:1)
3. Nezulcitinib Monohydrate
4. Td-0903
5. Td-0903 Monohydrate
6. Thrx-136377
7. Thrx-136377 Monohydrate
1. Nezulcitinib [inn]
2. Nezulcitinib [usan]
3. Thrx-136377
4. Cxa4i8ah6a
5. Td-0903
6. 2412496-23-0
7. (s)-(3-(dimethylamino)azetidin-1-yl)(2-(6-(2-ethyl-4-hydroxyphenyl)-1h-indazol-3-yl)-5-isopropyl-4,5,6,7-tetrahydro-3h-imidazo(4,5-c)pyridin-6-yl)methanone
8. [3-(dimethylamino)azetidin-1-yl]-[(6s)-2-[6-(2-ethyl-4-hydroxyphenyl)-1h-indazol-3-yl]-5-propan-2-yl-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-6-yl]methanone
9. Unii-cxa4i8ah6a
10. Nezulcitinib [who-dd]
11. Chembl4802163
12. Schembl21772319
13. Gtpl11304
14. Who 11732
15. Example 1 [wo2020051105a1]
16. Hy-132849
17. Cs-0204160
18. (3-(dimethylamino)azetidin-1-yl)((6s)-2-(6-(2-ethyl-4-hydroxyphenyl)-1h-indazol-3-yl)-5-(propan-2-yl)-4,5,6,7-tetrahydro-1h-imidazo(4,5-c)pyridin-6-yl)methanone
19. Methanone, (3-(dimethylamino)-1-azetidinyl)((6s)-2-(6-(2-ethyl-4-hydroxyphenyl)-1h-indazol-3-yl)-4,5,6,7-tetrahydro-5-(1-methylethyl)-3h-imidazo(4,5-c)pyridin-6-yl)-
| Molecular Weight | 527.7 g/mol |
|---|---|
| Molecular Formula | C30H37N7O2 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 527.30087345 g/mol |
| Monoisotopic Mass | 527.30087345 g/mol |
| Topological Polar Surface Area | 104 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 866 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Nezulcitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nezulcitinib, including repackagers and relabelers. The FDA regulates Nezulcitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nezulcitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nezulcitinib supplier is an individual or a company that provides Nezulcitinib active pharmaceutical ingredient (API) or Nezulcitinib finished formulations upon request. The Nezulcitinib suppliers may include Nezulcitinib API manufacturers, exporters, distributors and traders.
Nezulcitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nezulcitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nezulcitinib GMP manufacturer or Nezulcitinib GMP API supplier for your needs.
A Nezulcitinib CoA (Certificate of Analysis) is a formal document that attests to Nezulcitinib's compliance with Nezulcitinib specifications and serves as a tool for batch-level quality control.
Nezulcitinib CoA mostly includes findings from lab analyses of a specific batch. For each Nezulcitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nezulcitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Nezulcitinib EP), Nezulcitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nezulcitinib USP).
LOOKING FOR A SUPPLIER?
